FDA new drug approvals in Q3 2021

被引：2

|

作者：

Urquhart, Lisa ^{[1
]}

机构：

[1] Evaluate Vantage, London, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2021年 / 20卷 / 11期

关键词：

D O I：

10.1038/d41573-021-00175-8

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：807 / 807

页数：1

相关论文

共 50 条

[41] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
Lemery, Steven
Pazdur, Richard
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 217 - 218
[42] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
Steven Lemery
Richard Pazdur
[J]. Nature Reviews Clinical Oncology, 2022, 19 : 217 - 218
[43] FDA marks record year for new drug approvals
Challener, Cynthia A.
[J]. Pharmaceutical Technology, 2019, 43 (01) : 30 - 33
[44] 2016 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 73 - 76
[45] 2015 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2016, 15 : 73 - 76
[46] 2014 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2015, 14 : 77 - 81
[47] 2013 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2014, 13 : 85 - 89
[48] 2008 FDA drug approvals
Hughes, Bethan
[J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 93 - 96
[49] 2011 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2012, 11 (2) : 91 - 94
[50] Recent FDA drug approvals
Naccari, Christopher
[J]. CNS SPECTRUMS, 2008, 13 (06) : 466 - 466

← 1 2 3 4 5 →